Executive Summary
The latest India BSE FMCG filings center on upcoming Q4 FY 2025-26 and FY26 results disclosures, with Marico Limited scheduling a Board meeting on May 5, 2026, for audited financials, auditor's report, and final dividend recommendation, alongside an analyst conference call featuring MD/CEO Saugata Gupta and Group CFO Pawan Agrawal. Dabur India Limited announced an investors' conference call on May 7, 2026, to discuss the same period's results, providing dial-in and webcast access. Marico highlighted its FY24-25 turnover of ₹108.3 billion (overseas portfolio at 25% of revenue) as context, with trading window closed until May 7, 2026, per SEBI LODR. Sudarshan Chemical Industries (included for context) disclosed intent by Pradeep Rathi and Rahul Rathi to acquire shares under SEBI takeover regulations, signaling potential promoter consolidation amid low disclosure. All filings carry neutral sentiment and focus on scheduled events rather than new financial metrics or period-over-period trends, indicating an earnings catalyst cluster at sector start. No YoY/QoQ data released yet, but portfolio-level pattern shows 2/4 companies (Marico, Dabur) gearing for results amid closed trading windows, limiting insider activity visibility; implications include heightened volatility around May 5-7 and alpha from pre-event positioning.
Tracking the trend? Catch up on the prior BSE FMCG Sector Regulatory Filings digest from April 10, 2026.
Investment Signals(12)
- Marico Limited↓(BULLISH)▲
Board meeting May 5, 2026, to approve Q4/FY26 audited standalone/consolidated results, signaling timely compliance and potential positive surprises
- Marico Limited↓(BULLISH)▲
Recommendation of final equity dividend for FY25-26 at Board meeting May 5, building on historical capital allocation to shareholders
- Marico Limited↓(BULLISH)▲
Analyst conference call May 5, 2026, at 5:30 PM IST with MD/CEO Saugata Gupta and Group CFO Pawan Agrawal, offering direct management insights post-Board approval
- Marico Limited↓(BULLISH)▲
FY24-25 turnover of ₹108.3 billion with 25% from overseas consumer products, stable base for FY26 results discussion
- Dabur India Limited↓(BULLISH)▲
Investors' conference call May 7, 2026, at 5:00 PM IST with universal dial-in and webcast, enhancing transparency on Q4/FY26 results
- Sudarshan Chemical↓(BULLISH)▲
Pradeep Rathi and Rahul Rathi disclose intent to acquire shares under SEBI Reg 29(2), indicating promoter conviction and potential stake consolidation
- Marico Limited↓(BULLISH)▲
Trading window closed March 26 to May 7, 2026, per SEBI LODR Reg 29, preventing insider selling ahead of results
- Marico vs Dabur(BULLISH)▲
Closely timed conference calls (May 5 vs May 7) enable relative performance comparison on FY26 results, with Marico's dividend angle adding edge
- Sector(BULLISH)▲
3/4 filings from core FMCG (Marico x2, Dabur), clustering catalysts for portfolio rebalancing
- Sudarshan Chemical↓(BULLISH)▲
Low risk level on acquisition disclosure, with opportunities for promoter-led value unlock
- Marico Limited↓(BULLISH)▲
Audio recording and transcript to be published on website post-call, aiding post-event analysis
- Dabur India Limited↓(BULLISH)▲
Multiple toll-free dial-ins (India 1800-120-1221, international options) democratize access to guidance
Risk Flags(8)
- Sudarshan Chemical/Acquisition↓[HIGH RISK]▼
No disclosure on deal size, share count, % stake, valuation, or structure under SEBI Reg 29(2), creating uncertainty
- Sudarshan Chemical/Disclosure↓[MEDIUM RISK]▼
Lack of intent details may lead to market overreaction or stalled momentum
- Marico Limited/Trading Window↓[MEDIUM RISK]▼
Closed until May 7, 2026, post-results; watch for insider selling upon reopening if results disappoint
- Dabur India Limited/Event↓[LOW RISK]▼
Neutral sentiment (4/10 materiality) on conf call; risk of flat guidance amid no forward-looking previews
- Marico Limited/Event↓[MEDIUM RISK]▼
Neutral sentiment (7/10 and 5/10 materiality); board/analyst meets carry execution risk if FY26 results miss FY24-25 ₹108.3B base
- Sector/Insider Activity[LOW RISK]▼
No quantified holdings or transaction details across filings; limited conviction signals vs prior briefs
- Sudarshan Chemical/Outlier↓[MEDIUM RISK]▼
Non-core FMCG chemical play with acquisition risk if regulatory scrutiny delays
- Portfolio[LOW RISK]▼
1/4 filings (Sudarshan) with explicit risk factors; others neutral but no enriched period trends to confirm stability
Opportunities(10)
- Marico Limited/Board Meeting↓(OPPORTUNITY)◆
Position ahead of May 5, 2026, dividend recommendation for yield capture, historical capital allocation favors shareholders
- Marico Limited/Conf Call↓(OPPORTUNITY)◆
Dial-in May 5 for fresh FY27 guidance from CEO/CFO, leveraging 25% overseas revenue stability
- Dabur India Limited/Conf Call↓(OPPORTUNITY)◆
May 7 access via Diamond Pass/webcast for Q4/FY26 operational metrics and outlook
- Sudarshan Chemical/Stake Build↓(OPPORTUNITY)◆
Rathi brothers' acquisition intent offers promoter consolidation alpha, low 3/10 materiality undervalued
- Marico vs Sector(OPPORTUNITY)◆
Relative outperformance potential if dividend confirmed vs peers; compare to Dabur call 2 days later
- FMCG Earnings Cluster(OPPORTUNITY)◆
Pre-May 5/7 positioning across Marico/Dabur for sector rotation if guidance beats FY24-25 trends
- Marico Limited/Capital Allocation↓(OPPORTUNITY)◆
Final dividend approval at AGM post-May 5 creates record date catalyst
- Sudarshan Chemical/Promoter↓(OPPORTUNITY)◆
Monitor for crossing substantial thresholds, potential M&A follow-on
- Dabur India/Transparency↓(OPPORTUNITY)◆
One-way audio webcast enables broad investor participation, flag for guidance upgrades
- Marico Website(OPPORTUNITY)◆
Post-call transcripts for forensic analysis on international portfolio growth
Sector Themes(6)
- Earnings Catalyst Cluster◆
3/4 filings signal Q4/FY26 results focus (Marico May 5 board/call, Dabur May 7 call), kickstarting FMCG reporting season with May 5-7 density [IMPLICATION: Heightened volatility, pre-position for guidance]
- Neutral Sentiment Dominance◆
All 4 filings neutral (materiality 3-7/10), no bullish/bearish shifts; reflects procedural announcements vs financial reveals [IMPLICATION: Low conviction trades until results]
- Capital Allocation Spotlight◆
Marico's dividend recommendation unique among filings, vs no mentions in Dabur/Sudarshan [IMPLICATION: Shareholder returns theme, watch yield leaders]
- Insider Activity Emergence◆
Sudarshan Rathi acquisition intent (1/4 filings) as sole transaction signal, potential pattern if peers follow post-window [IMPLICATION: Promoter conviction scan post-May 7]
- Event Accessibility Trends◆
Multiple dial-ins/webcasts/Diamond Pass across Marico/Dabur (universal +91 22 numbers, toll-free), improving retail access vs historical [IMPLICATION: Broader participation, faster sentiment shifts]
- Trading Window Compliance◆
Marico closure to May 7 standard (SEBI LODR Reg 29), no pledges/splits noted across [IMPLICATION: Clean slate for results, monitor reopen trades]
Watch List(8)
Approve FY26 results, auditor report, dividend rec; May 5, 2026 [CRITICAL for guidance/dividend]
MD/CEO Saugata Gupta, CFO Pawan Agrawal discuss ops/results; May 5, 2026, 5:30 PM IST [WATCH guidance vs FY24-25 ₹108.3B]
Q4/FY26 results discussion; May 7, 2026, 5:00 PM IST [WATCH relative to Marico, operational metrics]
Pradeep/Rahul Rathi share purchases, threshold crossings; Ongoing post-Apr 17, 2026 disclosure [WATCH size/intent updates]
Reopens May 8, 2026; monitor insider buys/sells post-results [WATCH conviction signals]
Shareholder approval of final dividend post-May 5; Record date TBC [WATCH capital allocation execution]
- FMCG Sector/Results Season👁
Peer filings for Dabur/Marico comparables; May 2026 window [WATCH YoY/QoQ trends rollout]
Further Reg 29 disclosures on holdings/transactions [WATCH stake evolution]
Filing Analyses(4)
17-04-2026
Marico Limited announced a Board of Directors meeting scheduled for May 5, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, take on record the auditor's report, and recommend a final equity dividend for FY 2025-26 for shareholder approval at the 38th Annual General Meeting. The trading window for dealing in the company's shares remains closed from March 26, 2026, to May 7, 2026 (both days inclusive), in compliance with SEBI LODR Regulation 29.
- ·Scrip Code: 531642 (BSE)
- ·Scrip Symbol: MARICO (NSE)
- ·Filing addresses: BSE - 1st Floor, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001; NSE - Exchange Plaza, C-1 Block G, Bandra Kurla Complex, Bandra (East), Mumbai – 400051
17-04-2026
Dabur India Limited has announced an Investors' Conference Call scheduled for May 07, 2026, at 5:00 P.M. IST to discuss the Q4 FY 2025-26 Financial Results for the quarter and financial year ended March 31, 2026. The call provides universal dial-in numbers (+91 22 6280 1110, +91 22 7115 8011), India toll-free (1 800 120 1221), international toll-free options, Diamond Pass registration link, and a one-way audio webcast on the company's website. This disclosure is made pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015.
- ·BSE Scrip Code: 500096
- ·NSE Scrip Symbol: DABUR
- ·Filing Reference: SEC/SE/2026-27
- ·Company CIN: L24230DL1975PLC007908
- ·Registered Office: 8/3, Asaf Ali Road, New Delhi – 110 002
17-04-2026
Marico Limited has scheduled an investor/analyst conference call on Tuesday, May 5, 2026, at 5:30 p.m. IST, where management will discuss the financial results and operations for the quarter and financial year ended March 31, 2026, following Board approval on the same day. Key participants include Mr. Saugata Gupta (Managing Director & CEO) and Mr. Pawan Agrawal (Group CFO & CEO - International Business). The company provides background on its FY24-25 turnover of ₹108.3 billion, with the overseas consumer products portfolio contributing 25% of Group revenue.
- ·Conference call details: Universal Dial-In (+91 22) 6280 1558 or (+91 22) 7115 8384; international toll-free numbers provided for USA, UK, Singapore, Hong Kong.
- ·Live webcast available; diamond pass registration for direct access without queue.
- ·Audio recording and transcript to be published on https://marico.com/india/investors#quarterly.
- ·Financial results to be available on www.marico.com after Board approval on May 5, 2026.
17-04-2026
Sudarshan Chemical Industries Ltd (BSE: 506655) has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Pradeep Rathi and Rahul Rathi. This filing indicates their intention to acquire shares in the company, potentially crossing substantial acquisition thresholds. No details on deal size, share count, percentage stake, valuation, or transaction structure are disclosed.
- ·Stock code: 506655
- ·Source: BSE
Get daily alerts with 12 investment signals, 8 risk alerts, 10 opportunities and full AI analysis of all 4 filings
More from: BSE FMCG Sector Regulatory Filings
🇮🇳 More from India
View all →April 10, 2026
India Pre-Market Regulatory Roundup — April 10, 2026
India Pre-Market Regulatory Roundup
April 10, 2026
India Quarterly Results BSE NSE Announcements — April 10, 2026
India Quarterly Results BSE NSE Announcements
April 10, 2026
India Upcoming Corporate Actions BSE NSE — April 10, 2026
India Upcoming Corporate Actions BSE NSE
April 10, 2026
India Merger Acquisition MCA Regulatory Filings — April 10, 2026
India Merger Acquisition MCA Regulatory Filings